Nokia Oyj
Correction: Changes in Nokia Corporation's own shares
Correction: Changes in Nokia Corporation's own shares
Nokia Corporation
Stock Exchange Release
11 December 2025 at 16:30 EET
Correction: Changes in Nokia Corporation's own shares
Espoo, Finland – the stock exchange release of Nokia Corporation titled “Changes in Nokia Corporation’s Own Shares” published on 9 December 2025 incorrectly stated that the number of own shares held by Nokia Corporation following the transfer was 149 246 864. The correct number is 148 246 864.
The corrected stock exchange release in its entirety can be found below.
Espoo, Finland – A total of 1 020 316 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia's equity-based incentive plans in accordance with the rules of the plans. The transfer is based on the resolution of the Board of Directors to issue shares held by the company to settle its commitments to participants of the incentive plans as announced on 22 November 2024.
The number of own shares held by Nokia Corporation following the transfer is 148 246 864.
About Nokia
Nokia is a global leader in connectivity for the AI era. With expertise across fixed, mobile, and transport networks, we’re advancing connectivity to secure a brighter world.
Inquiries:
Nokia
Communications
Phone: +358 10 448 4900
Email: press.services@nokia.com
Maria Vaismaa, Vice President, Global Media Relations
Nokia
Investor Relations
Phone: +358 931 580 507
Email: investor.relations@nokia.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Brødrene A. & O. Johansen A/S11.12.2025 17:23:40 CET | Pressemeddelelse
Finanskalender 2026
Io Therapeutics, Inc.11.12.2025 17:05:00 CET | Press release
Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical studies demonstrating effectiveness of IRX4204, the company’s clinical stage retinoid X nuclear receptor (RXR) agonist compound, for synergistically promoting killing of HER2+ breast cancer cells in combination with HER2-targeted chimeric antigen receptor modified T-cells (CAR-T).
Camposol SA11.12.2025 17:00:00 CET | Press release
Camposol Holding PLC appoints Julio Alcalde as Chief Financial Officer.
Oma Säästöpankki Oyj11.12.2025 16:50:00 CET | Press release
Oma Savings Bank Plc: The investigation related to securities market offences has been completed
Gabriel Holding A/S11.12.2025 15:10:10 CET | Press release
Minutes of the annual general meeting on 11 December 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom